Sunday, December 1, 2019

Sun Pharma to defend antitrust claims over delayed entry of 3 generic drugs in US

Sun Pharma to defend antitrust claims over delayed entry of 3 generic drugs in US Sun Pharma said the litigation had already been disclosed in the company#39;s FY19 annual report.

from Moneycontrol Business News https://ift.tt/2ODfudW
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US stock: S&P 500 ends lower as investors weigh data, Middle East tensions

The S&P 500's streak came to an end, falling from its peak as weaker retail sales suggested caution among consumers. Despite a stron...